Research reveals the esophageal microbiome influences disease development, suggesting potential for clinical applications.
The esophageal microbiome influences disease pathogenesis and has potential for risk stratification and therapeutic targeting. Future progress will depend on longitudinal studies, improved functional resolution, and integration of microbial data with epithelial and immune biology to enable clinical translation.
No takes yet. Share an insight, caveat, or question.
Nonyelum Ebigbo (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: